BR9811458A - "sistema solvente para penetração melhorada de compostos farmacêuticos" - Google Patents
"sistema solvente para penetração melhorada de compostos farmacêuticos"Info
- Publication number
- BR9811458A BR9811458A BR9811458-1A BR9811458A BR9811458A BR 9811458 A BR9811458 A BR 9811458A BR 9811458 A BR9811458 A BR 9811458A BR 9811458 A BR9811458 A BR 9811458A
- Authority
- BR
- Brazil
- Prior art keywords
- solvent system
- pharmaceutical compounds
- improved penetration
- penetration
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000002904 solvent Substances 0.000 title abstract 4
- 230000035515 penetration Effects 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82909197A | 1997-03-31 | 1997-03-31 | |
| PCT/US1998/004033 WO1998043673A1 (fr) | 1997-03-31 | 1998-03-03 | Systeme de solvant pour ameliorer la penetration de composes pharmaceutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9811458A true BR9811458A (pt) | 2000-09-19 |
Family
ID=25253504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9811458-1A BR9811458A (pt) | 1997-03-31 | 1998-03-03 | "sistema solvente para penetração melhorada de compostos farmacêuticos" |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0971746A1 (fr) |
| JP (1) | JP2001518879A (fr) |
| KR (1) | KR19980081207A (fr) |
| CN (1) | CN1252003A (fr) |
| AR (1) | AR012217A1 (fr) |
| AU (1) | AU6677698A (fr) |
| BR (1) | BR9811458A (fr) |
| CA (1) | CA2285368A1 (fr) |
| CO (1) | CO5050328A1 (fr) |
| HU (1) | HUP0001739A3 (fr) |
| IL (1) | IL132096A0 (fr) |
| PL (1) | PL335934A1 (fr) |
| WO (1) | WO1998043673A1 (fr) |
| ZA (1) | ZA982662B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2232855C (fr) * | 1997-04-10 | 2007-10-09 | Roche Consumer Health (Worldwide) Sa | Preparation pharmaceutique |
| AU5146600A (en) * | 1999-05-27 | 2000-12-18 | Procter & Gamble Company, The | Topical compositions providing improved treatment of skin or scalp fungal infections |
| GB0103046D0 (en) | 2001-02-07 | 2001-03-21 | Novartis Ag | Organic Compounds |
| IL142037A0 (en) * | 2001-03-15 | 2002-03-10 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug |
| MY129350A (en) * | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
| JP5435836B2 (ja) * | 2003-07-03 | 2014-03-05 | 大正製薬株式会社 | 外用抗真菌剤組成物 |
| JP4784051B2 (ja) * | 2003-07-03 | 2011-09-28 | 大正製薬株式会社 | 容器への吸着を防止した外用抗真菌組成物 |
| DE102005059742A1 (de) | 2005-12-13 | 2007-06-14 | Beiersdorf Ag | Transparentes Sonnenschutzmittel |
| US20080032994A1 (en) | 2006-08-03 | 2008-02-07 | Marcel Borgers | Modified azole compounds as antifungal and antibacterial agents |
| DK2079441T3 (da) * | 2007-07-25 | 2010-12-13 | Ixodes Gmbh | Topisk antibiotisk sammensætning til forebyggelse af Lyme's sygdom |
| JP5313905B2 (ja) * | 2007-08-27 | 2013-10-09 | 日本農薬株式会社 | 真菌性皮膚炎用剤 |
| US20090175810A1 (en) | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
| US8039494B1 (en) | 2010-07-08 | 2011-10-18 | Dow Pharmaceutical Sciences, Inc. | Compositions and methods for treating diseases of the nail |
| US9839611B2 (en) * | 2013-09-10 | 2017-12-12 | Insys Development Company, Inc. | Sublingual buprenorphine spray |
| SG11201602596UA (en) | 2013-10-03 | 2016-04-28 | Dow Pharmaceutical Sciences | Stabilized efinaconazole compositions |
| EP3071295A4 (fr) | 2013-11-22 | 2017-05-31 | Dow Pharmaceutical Sciences, Inc. | Procédés, compositions et dispositifs anti-infectieux |
| CN115745757B (zh) * | 2022-11-07 | 2024-04-26 | 中国人民解放军军事科学院军事医学研究院 | 一种液态多甘醇柱芳烃衍生物的合成及对经皮药效分子缓释的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT89837B (pt) * | 1988-02-29 | 1994-01-31 | Pfizer | Processo para a preparacao de composicoes para aumentar o fluxo transdermico contendo uma 1-alquilazaciclo-heptan-2-ona ou uma cis-olefina |
| GB8827822D0 (en) * | 1988-11-29 | 1988-12-29 | Janssen Pharmaceutica Nv | (1h-azol-1-ylmethyl)substituted quinoline derivatives |
| CN1106259A (zh) * | 1994-02-05 | 1995-08-09 | 日东制药株式会社 | 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂 |
-
1998
- 1998-03-03 CA CA002285368A patent/CA2285368A1/fr not_active Abandoned
- 1998-03-03 PL PL98335934A patent/PL335934A1/xx unknown
- 1998-03-03 AU AU66776/98A patent/AU6677698A/en not_active Abandoned
- 1998-03-03 EP EP98908843A patent/EP0971746A1/fr not_active Withdrawn
- 1998-03-03 HU HU0001739A patent/HUP0001739A3/hu unknown
- 1998-03-03 JP JP54163598A patent/JP2001518879A/ja active Pending
- 1998-03-03 BR BR9811458-1A patent/BR9811458A/pt not_active Application Discontinuation
- 1998-03-03 CN CN98803908A patent/CN1252003A/zh active Pending
- 1998-03-03 IL IL13209698A patent/IL132096A0/xx unknown
- 1998-03-03 WO PCT/US1998/004033 patent/WO1998043673A1/fr not_active Application Discontinuation
- 1998-03-30 ZA ZA9802662A patent/ZA982662B/xx unknown
- 1998-03-31 AR ARP980101461A patent/AR012217A1/es unknown
- 1998-03-31 CO CO98017937A patent/CO5050328A1/es unknown
- 1998-03-31 KR KR1019980012493A patent/KR19980081207A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1252003A (zh) | 2000-05-03 |
| CO5050328A1 (es) | 2001-06-27 |
| HUP0001739A3 (en) | 2001-04-28 |
| EP0971746A1 (fr) | 2000-01-19 |
| WO1998043673A1 (fr) | 1998-10-08 |
| AU6677698A (en) | 1998-10-22 |
| CA2285368A1 (fr) | 1998-10-08 |
| KR19980081207A (ko) | 1998-11-25 |
| AR012217A1 (es) | 2000-09-27 |
| HUP0001739A2 (hu) | 2000-12-28 |
| PL335934A1 (en) | 2000-05-22 |
| IL132096A0 (en) | 2001-03-19 |
| JP2001518879A (ja) | 2001-10-16 |
| ZA982662B (en) | 1999-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9811458A (pt) | "sistema solvente para penetração melhorada de compostos farmacêuticos" | |
| BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
| PT1087750E (pt) | Formulacoes farmaceuticas para aerossois com duas ou mais substancias activas | |
| DZ2614A1 (fr) | Compositions pharmaceutiques topiques contenant des dérivés de résorcinol. | |
| IT1283102B1 (it) | Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele | |
| BR0014384A (pt) | Compostos para o tratamento da isquémia | |
| FR2784294B1 (fr) | Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique | |
| BR9709062A (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
| ES2162927T3 (es) | Formulacion para la aplicacion por inhalacion. | |
| BR9803300A (pt) | Formulação farmacêutica. | |
| BR9811249A (pt) | Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma | |
| BR9810312A (pt) | Composição farmacêutica que apresenta atividade antitumoral acentuada e/ou efeitos colaterais reduzidos contendo um agente antitumoral e um derivado do ácido hidroxìmico | |
| BR9709915A (pt) | Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto | |
| BR9807234A (pt) | Composição farmacêutica | |
| BR0014818A (pt) | Imidazo-3-il-aminas bicìclicas procedimento de preparação e medicamentos que contém como substância ativa pelo menos uma imidazo-3-il-amina bicìclica | |
| BR0207872A (pt) | Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração | |
| ES2149305T3 (es) | Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y procedimientos de uso. | |
| BR0013009A (pt) | Uso de antagonistas de cgrp e de inibidores de liberação de cgrp para combate a jatos quentes menopáusicos | |
| BR9809508A (pt) | Agente terapêutico para disfunção de ereção | |
| BR9913135A (pt) | Formulação oral | |
| BR9908427A (pt) | Composições farmacêuticas e uso das mesmas | |
| BR9712141A (pt) | Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas. | |
| FR2598320B1 (fr) | Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques | |
| DE59914183D1 (de) | Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz | |
| BR0013582A (pt) | Agonistas retinóides seletivos para rar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |